{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T08:53:53Z","timestamp":1768553633864,"version":"3.49.0"},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":732,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1111\/bjd.12378","type":"journal-article","created":{"date-parts":[[2013,4,12]],"date-time":"2013-04-12T14:58:47Z","timestamp":1365778727000},"page":"653-659","source":"Crossref","is-referenced-by-count":23,"title":["Long-term response to hydroxychloroquine in patients with discoid lupus erythematosus"],"prefix":"10.1093","volume":"169","author":[{"given":"S.","family":"Wahie","sequence":"first","affiliation":[{"name":"Institute of Cellular Medicine; Newcastle University; Newcastle upon Tyne; NE2 4HH; U.K"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.J.","family":"Meggitt","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Royal Victoria Infirmary; Newcastle upon Tyne; NE2 4HH; U.K"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2013,8,30]]},"reference":[{"key":"10.1111\/bjd.12378-BIB0001|bjd12378-cit-0001","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2165\/11310780-000000000-00000","article-title":"Cutaneous lupus erythematosus: issues in diagnosis and treatment","volume":"10","author":"Walling","year":"2009","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/bjd.12378-BIB0002|bjd12378-cit-0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00128071-200506010-00001","article-title":"Optimal use of antimalarials in treating cutaneous lupus erythematosus","volume":"6","author":"Wozniacka","year":"2005","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/bjd.12378-BIB0003|bjd12378-cit-0003","first-page":"CD002954","article-title":"Drugs for discoid lupus erythematosus","volume":"7","author":"Jessop","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/bjd.12378-BIB0004|bjd12378-cit-0004","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2133.1992.tb14851.x","article-title":"Treatment of cutaneous lupus erythematosus with acitretin and hydroxychloroquine","volume":"127","author":"Ruzicka","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12378-BIB0005|bjd12378-cit-0005","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1038\/jid.2011.167","article-title":"Clinical and pharmacogenetic influences on response to hydroxychloroquine in discoid lupus erythematosus: a retrospective cohort study","volume":"131","author":"Wahie","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12378-BIB0006|bjd12378-cit-0006","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1159\/000246899","article-title":"The association of the two antimalarials chloroquine and quinacrine for treatment-resistant chronic and subacute cutaneous lupus erythematosus","volume":"189","author":"Feldmann","year":"1994","journal-title":"Dermatology"},{"key":"10.1111\/bjd.12378-BIB0007|bjd12378-cit-0007","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1191\/096120300678828082","article-title":"The benefit of combining hydroxychloroquine with quinacrine in the treatment of SLE patients","volume":"9","author":"Toubi","year":"2000","journal-title":"Lupus"},{"key":"10.1111\/bjd.12378-BIB0008|bjd12378-cit-0008","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1177\/0961203308101714","article-title":"Treatment of lupus skin involvement with quinacrine and hydroxychloroquine","volume":"18","author":"Cavazzana","year":"2009","journal-title":"Lupus"},{"key":"10.1111\/bjd.12378-BIB0009|bjd12378-cit-0009","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/archdermatol.2011.191","article-title":"Response to antimalarial agents in cutaneous lupus erythematosus: a prospective analysis","volume":"147","author":"Chang","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12378-BIB0010|bjd12378-cit-0010","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/ncprheum0380","article-title":"Drug insight: resistance to methotrexate and other disease-modifying antirheumatic drugs - from bench to bedside","volume":"3","author":"Heijden","year":"2007","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1111\/bjd.12378-BIB0011|bjd12378-cit-0011","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/art.21569","article-title":"Acquired resistance to chloroquine in human CEM T cells is mediated by multidrug resistance-associated protein 1 and provokes high levels of cross-resistance to glucocorticoids","volume":"54","author":"Oerlemans","year":"2006","journal-title":"Arthritis Rheum"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.12378","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.12378\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:05:11Z","timestamp":1676383511000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/169\/3\/653\/6615143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,30]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.12378","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8,30]]}}}